The action of 5,6-dihydroxytryptamine on 5-hydroxytryptamine receptors
Carruba, M.
Advances in Biochemical Psychopharmacology 10: 103-107
1974
ISSN/ISBN: 0065-2229 PMID: 4846534 Document Number: 80269
Document emailed within 1 workday
Related Documents
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410Seong, Y.H.; Baba, A.; Matsuda, T.; Iwata, H. 1990: 5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: involvement of multiple 5-hydroxytryptamine receptors Journal of Pharmacology and Experimental Therapeutics 254(3): 1012-1016
McCreary, A.C.; Bankson, M.G.; Cunningham, K.A. 1999: Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors Journal of Pharmacology and Experimental Therapeutics 290(3): 965-973
Björklund, A.; Baumgarten, H.G.; Nobin, A. 1974: Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine Advances in Biochemical Psychopharmacology 10: 13-33
Mayer, S.E.; Sanders-Bush, E. 1994: 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport Molecular Pharmacology 45(5): 991-996
Ononiwu, I.M.; Allagoa, D.O.; Nwangwu, J.E.; Ebong, O.O. 2002: Some studies on the 5-hydroxytryptamine receptors in the isolated rat uterus African Journal of Medicine and Medical Sciences 31(4): 361-365
Del Bianco, P.L.; Franchi, G.; Fanciullacci, M.; Sicuteri, F. 1972: Clinical pharmacology of 5-hydroxytryptamine and catecholamines venomotor receptors Archives Internationales de Pharmacodynamie et de Therapie 196: Suppl 196: 113
Foy, R.A.; Myles, J.L.; Wilkerson, R.D. 1992: Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries Journal of Pharmacology and Experimental Therapeutics 261(2): 601-606
Minami, M.; Tamakai, H.; Ogawa, T.; Endo, T.; Hamaue, N.; Hirafuji, M.; Yoshioka, M.; Blower, P.R. 1995: Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine Research Communications in Molecular Pathology and Pharmacology 89(2): 131-142
Hedge, S.S.; Moy, T.M.; Perry, M.R.; Loeb, M.; Eglen, R.M. 1994: Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice Journal of Pharmacology and Experimental Therapeutics 271(2): 741-747
Chojnacka-Wójcik, E.; Kłodzińska, A. 1997: Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOi in rats Polish Journal of Pharmacology 49(5): 299-304
Kostowski, W.; Kwiatkowska, B.; Widy-Tyszkiewicz, E. 1973: The action of some catecholamines and 5-hydroxytryptamine on heart in lower vertebrates Acta Physiologica Polonica 24(1): 275-279
Assaf, S.Y.; Crunelli, V.; Kelly, J.S. 1981: Action of 5-hydroxytryptamine on granule cells in the rat hippocampal slice Journal de Physiologie 77(2-3): 377-380
Aune, T.M.; McGrath, K.M.; Sarr, T.; Bombara, M.P.; Kelley, K.A. 1993: Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine Journal of Immunology 151(3): 1175-1183
Stollak, J.S.; Furchgott, R.F. 1983: Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta Journal of Pharmacology and Experimental Therapeutics 224(1): 215-221
Dun, N.J.; Karczmar, A.G. 1981: Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine in a mammalian sympathetic ganglion Journal of Pharmacology and Experimental Therapeutics 217(3): 714-718
Czyrak, A.; Skuza, G.; Rogóz, Z.; Frankiewicz, T.; Maj, J. 1994: Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes Arzneimittel-Forschung 44(2): 113-118
Cohen, M.L.; Robertson, D.W.; Bloomquist, W.E.; Wilson, H.C. 1992: LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis Journal of Pharmacology and Experimental Therapeutics 261(1): 202-208
Ollivier, Y.; Chauvel, Y.; Samperez, S.; Jouan, P. 1975: Plasma transport of 5-hydroxytryptamine-3H. I. Nature and classification of indole derivatives after injection of 5-hydroxytryptamine-3H Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(2): 408-412
Contesse, V.; Hamel, C.; Lefebvre, H.; Dumuis, A.; Vaudry, H.; Delarue, C. 1996: Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion Molecular Pharmacology 49(3): 481-493